Neudle.com: alpha agonists

Differential
(Click to cross reference)

activated protein C resistance

acute intermittant porphyria

addiction, heroin

advances in neurology

adverse drug reaction

agitation

akathisia

alcohol

alcohol, neurologic complications with

alcoholic withdrawal states, DT's, convulsions, etc.

Alzheimer's disease, treatment of

amphetamines, dyskinesia associated with

angiitis, granulomatous of CNS

angiography, cerebral, beaded vessels

angiography, cerebral

angiography, posterior fossa

antiarrhythmic drugs

antibiotics

antibiotics, neurologic complications with

anticoagulant, complications of

anticoagulant, restarting

anticoagulant, treatment

anticoagulant, treatment in CVD

anticonvulsants

anticonvulsants, blood level determination of

anticonvulsants, compliance

anticonvulsants, discontinuation in seizure-free epileptics

anticonvulsants, dosage

anticonvulsants, effectiveness

anticonvulsants, selection of

anticonvulsants, teratogenicity of

anticonvulsants, untoward effects of

antidepressant

antimalarials

antioxidant

antiphospholipid antibodies

antithrombin III deficiency

arterial dissection, carotid

arterial dissection, multiple

arterial dissection, vertebral

arthralgia

arthritis

aspirin

atherosclerosis, premature

atrial myxoma

atrial septal aneurysm

attention deficit disorder with hyperactivity

autonomic dysfunction

axonal degeneration

Babinski sign

basal ganglia, infarction

basal ganglia, lesion of

behavior modification

behavioral disorder

benign sexual headache

benzodiazepine

beta adrenergic blocker

bevacizumab

blood dyscrasias, neurologic findings with

calcitonin gene related peptide

calcitonin gene-related peptide receptor blocker

calcium antagonist

calcium antagonist, side effects of

cancer, cerebrovascular accident complicating patients with

cardiovascular disease

carotid angiogram

carotid artery atherosclerosis

carotid artery disease

carotid artery stenosis

carotid artery stenosis, intracranial

CAT scan, angiography

CAT scan, cord sign

CAT scan, hyperattenuation

CAT scan, venography

cavernous sinus, syndrome

cavernous sinus, thrombosis

central retinal artery occlusion

cerebellar hemorrhage

cerebellar infarction

cerebral edema

cerebral edema, origin and treatment

cerebral embolism

cerebral infarction

cerebral infarction, hemorrhagic

cerebral ischemia

cerebral veins

cerebral venous infarction

cerebral venous thrombosis

cerebral venous thrombosis, deep

cerebral venous thrombosis, etiology

cerebral venous thrombosis, recurrent

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, xanthochromia of

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, atrial myxoma

cerebrovascular accident, complications with

cerebrovascular accident, cryptogenic

cerebrovascular accident, differential diagnosis of

cerebrovascular accident, etiology

cerebrovascular accident, non atherosclerotic cause of

cerebrovascular accident, prevention of

cerebrovascular accident, prognosis in

cerebrovascular accident, recurrent

cerebrovascular accident, secondary prevention

cerebrovascular accident, sex distribution

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, women

cerebrovascular accident, young adult

cerebrovascular disease

cerebrovascular disease, predisposed factor in

cerebrovascular disease, risk factors in

cerebrovascular disease, smoking in

cervical spine injury

cervical spine manipulation

chemosis

chest pain

Chiari Frommel syndrome

children

chiropractic manipulation

Clinical Pathologic Conference(C.P.C.)

collagen vascular disease

congenital birth defects

congenital malformation

congenital malformation, non CNS

congestive heart failure

constipation

controversies in neurology

coprolalia

corneal dystrophy

corpus callosum, infarction of

cortical vein thrombosis

cost effectiveness

coumarin

coumarin, restarting treatment

counselling

craniectomy, decompressive

delivery, complicated

developmental retardation

dextran

diabetes insipidus

diabetes mellitus

diabetes mellitus, chemical

diagnostic criteria

diet

differential diagnosis

difficulty climbing stairs

dilantin

disorientation

disseminated intravascular coagulation(DIC)

diurnal variation

dopamine agonist

dopamine antagonist

downward deviation of eyes

drowsiness

drug abuse

drug abuse, neurologic complications of

drug induced neurologic disorders

drug interactions

drug of choice

drug withdrawal

dural arteriovenous malformation

dural sinus thrombosis

Durett hemorrhages

dyskinesia, buccal lingual facial

electroencephalogram, abnormalities of

epidemiology of neurology

erythropoietin treatment

evidence-based research

eye movement, painful

facial pain

facial weakness, bilateral

fibrinolytic agents, intra-venous local infusion

fibromuscular dysplasia

fine motor function, impaired

genetic neurologic disorders

Gilles de la Tourette syndrome

glucose tolerance test, abnormal

growth hormone

grunting

guanfacine

hallucination, auditory

hallucination, olfactory

headache, drug induced

headache, episodic

headache, progressive

headache, prophylaxis

headache, recurrent

headache, severe

headache, sudden onset of

headache, throbbing

headache, thunderclap

headache, treatment of

headache, unilateral

headache, vascular

headache, worst of life

hearing loss

hearing loss, sudden, unilateral

heart wall motion dysfunction

hematoma, intracerebral

hemianopia

hemoglobin abnormality, neurologic complications of

hemoglobinuria

hemolysis

heparin

heralding manifestation

hypercoagulable state

hypereosinophilic syndrome(HES)

hyperhidrosis

hyperhidrosis, unilateral

hypernephroma

hypersomnia

hypertension

hypertension, paroxysmal

hypocomplementemia

hyponatremia

hypoosmolality of serum

inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with

incidence

inclusion bodies

internal cerebral vein

intracerebral hemorrhage

intracerebral hemorrhage, multiple

intracerebral hemorrhage, young adult

intracranial hypertension, benign

intracranial hypertension, benign, incidence of

intracranial pressure, increased

Korsakoff's psychosis

labor, complicated

lactic dehydrogenase(LDH)

lamotrigine

lateral sinus

lateral sinus thrombosis

L-dopa

L-dopa, drug interactions with and side effects of

LE cell preparation

learning disability, in children

lergotrile

level of consciousness, decreased

levonorgestrel

Lewy body

Lewy body disease, diffuse

lidocaine

lidocaine, intravenous

lifestyle

lithium

lumbar puncture, complications of

memory, disorder, treatment of

menopause

menses

menses, seizure with

mental status, abnormal

migraine, pathogenesis

migraine, prophylaxis

migraine, treatment of

mimics

misdiagnosis

modafinil

monoamine oxidase inhibitors

monoclonal antibodies

mononeuropathy

mortality

movement disorder

movement disorder, drug induced

MRI, CAT scan compared to

MRI, contrast enhanced

multiple sclerosis, risk factors for

multiple system atrophy

muscle weakness

muscle weakness, proximal

myasthenia gravis

myasthenia gravis, drug induced

myasthenia gravis, unmasked

myasthenic syndrome

myocardial infarction

neoplasm, pituitary, treatment of

neurocardiology

neuroleptic

neuroleptic, atypical

neurologic complications of, systemic cancer

neurologic complications of, systemic disease

neurologic disease

neurologic disease, diagnoses of

neurologic examination, focal

neurologic symptoms

neuromuscular blockade

neuropathology

neuropathology, brain

neuropathy

neuropathy, etiologies of

neuropathy, painful

neuropathy, peripheral, treatment

neuroprotective agents

neurotransmitter

nonsteroidal anti-inflammatory drug

non-vitamin K antagonist oral anticoagulants

nortriptyline

obesity

obsessive-compulsive disorder

obstetric neurologic injuries

Ollier's disease(enchondromas, multiple)

opiate

optic atrophy

oral contraceptives

oral contraceptives, cerbrovascular disease and

oral contraceptives, choreiform movements with

oral contraceptives, neurologic complications with

otitis, neurologic complications with

pain, management of chronic

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, etiology of

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, treatment of

Parkinsonism multiple-system atrophy

paroxysmal nocturnal hemoglobinuria

patent foramen ovale

pathology

patient information and support

pelvic deep venous thrombosis

pemoline

penicillamine

periarteritis nodosa

persistent eustacian valve

personality change

phenothiazine

phenothiazine, dyskinesia associated with

pituitary, microadenoma

pizotifen

placebo effect

platelet inhibiting drugs

pleurisy

polyneuropathy

post herpetic neuralgia

posterior fossa

posterior leukoencephalopathy syndrome

postpartum

practice guidelines

precipitating factors

pregnancy, anticonvulsants during

pregnancy, neurologic complications in

premarin

premonitory urges

prenatal diagnosis by amniocentesis

prethrombotic state

prevention of neurologic disorders

primary intracranial hypotension

primary thrombocythemia

procainamide

progesterone

prognosis

progressive neurologic disorder

psychiatric problems in neurologic disorders

quadriparesis, progressive

remote effect of cancer on the nervous system

renal failure

restless leg syndrome

reversible cerebral vasoconstrictive syndromes

review article

rheumatic heart disease

rigidity

rimegepant

risk factors

risk-benefit assessment

seizure, classification of

seizure, diagnosis of

seizure, diencephalic

seizure, non-treatment of

seizure, pregnancy

seizure, psychomotor-temporal lobe

seizure, treatment of

seizure, treatment of, first

seizure, treatment of, monotherapy

seizure, withdrawal

seizure, women

seizure, workup of

selective serotonin reuptake inhibitors

sensorineural hearing loss

single photon emission computed tomography

skull x-ray

skull x-ray, abnormal

sleep

sleep pathology and physiology

smell

sniffing

somnolence

splenic-vein thrombosis

splenomegaly

stem cell transplantation

steroid

steroid therapy, CNS treatment and complications with

stillbirth

stimulant drugs

stimulation, deep brain

straight sinus

strokelike episodes

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

sumatriptan

superior petrosal sinus

superior sagittal sinus thrombosis

symmetric brain lesions

synucleinopathy

systemic illness

systemic lupus erythematosus

systemic lupus erythematosus, drug induced

tachycardia

Takotsubo cardiomyopathy

tamoxifen

tardive dyskinesia

temporal lobe, lesion

teratogenesis

teratogenic drugs

tetanus antitoxin

thalamus, infarction of

thalamus, lesion of

thalamus, lesion of-bilateral

tic, chronic multiple

tic, classification of

tissue plasminogen activator, intravenous

topiramate

transient ischemic attack

trauma

treatment of neurologic disorder

tremor

tricyclic antidepressant

trifluoperazine

trigeminovascular system

ultrasonography, head, fetus-neonate

undiagnosed

upgaze, paralysis of

urine osmolality, elevated

urokinase

vagus nerve stimulation

venous thrombosis, non-cerebral

vitamin supplementation

watershed infarcts

Watson-Schwartz reaction

weakness

weakness, generalized

weakness, progressive

workup

zonisamide

Showing articles 300 to 350 of 687 << Previous Next >>

Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

Othello Syndrome in Parkinson Disease Patients Without Dementia
The Neurologist 15:34-36, Cannas,A.,et al, 2009

Anti-Tumor Necrosis Factor Alpha-Associated Multiple Sclerosis
AJNR 26:1548-1550, Titelbaum,D.S.,et al., 2008

Assessment: The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 71:766-773, Goodin,D.S.,et al., 2008

Second Consensus Statement on the Diagnosis of Multiple System Atrophy
Neurol 71:670-676, Gilman,S.,et al., 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008

Functional Abnormalities Underlying Pathological Gambling in Parkinson Disease
Arch Neurol 65:1604-1611, Cilia,R.,et al, 2008

Natalizumab Use in Pediatric Multiple Sclerosis
Arch Neurol 65:1655-1658, Huppke,P.,et al, 2008

Response of Anti-NMDA Receptor Encephalitis Without Tumor to Immunotherapy Including Rituximab
Neurol 71:1921-1923, Ishiura,H.,et al, 2008

Levodopa for the Treatment of Parkinsons Disease
NEJM 359:2468-2476, LeWitt,P.A., 2008

Treatment of Neuromyelitis Optica with Rituximab; Retrospective Analysis of 25 Patients
Arch Neurol 65:1443-1448, Jacob,A.,et al, 2008

Lymphomatoid Granulomatosis Involving Central Nervous System Successfully Treated With Rituximab alone
Arch Neurol 65:662-665, Ishiura,H.,et al, 2008

Clinicopath Conf., Endheim-Chester Disease
NEJM 359:736-747, Case 25-2008, 2008

Fourteen-Year Final Report of the Randomized PDRG-UK Trial Comparing Three Treatments in PD
Neurol 71:474-480.470, Katzenschlager,R.,et al., 2008

Neurogenic Orthostatic Hypotension
NEJM 358:615-624, Freeman,R., 2008

a-Synuclein Gene Duplication Is Present in Sporadic Parkinson Disease
Neurol 70:43-49,7, Ahn,T.-B.,et al, 2008

Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stoke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)
Stroke 39:89-99, Adams,H.P.,Jr.,et al, 2008

B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008

Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008

Restless Arms
Lancet 371:530, Horvath,J.,et al, 2008

Acute Treatment and Prevention of Menstrually Related Migraine Headache: Evidence-Based Review
Neurol 70:1555-1563, Pringsheim,T.,et al, 2008

A case of rheumatoid arthritis complicated by demyelination in both cerebral cortex and spinal cord during etanercept therapy
Mod Rheumatol 18:399-402, Kameda, T.,et al, 2008

Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis
Mod Rheumatol 17-72-74, Yamamoto, M.,et al, 2007

Intracranial Hemorrhage in Patients Treated with Bevacizumab and Low-Molecular Weight Heparin
Clin Adv Hematol Oncol 5:375-379, Nguyen, T.D.,et al, 2007

Rapidly Fatal Acanthamoeba Encephalitis and Treatment of Cryoglobulinemia
Emerg Infect Dis 13:469-471, Meersseman, W.,et al, 2007

Ropinirole 24-Hour Prolonged Release: Randomized, Controlled Study in Advanced Parkinson Disease
Neurol 68:1108-1115, Pahwa,R.,et al, 2007

Valvular Heart Disease and the Use of Dopamine Agonists for Parkinsons Disease
NEJM 356:39-46, Zanettini,R.,et al, 2007

Dopamine Agonists and the Risk of Cardiac Valve Regurgitation
NEJM 356:29-38, Schade,R.,et al, 2007

Randomized, Blind, Controlled Trial of Transdermal Rotigotine in Early Parkinson Disease
Neurol 68:272-276, Watts,R.L.,et al, 2007

Pathologic Gambling in Patients with Restless Legs Syndrome Treated With Dopaminergic Agonists
Neurol 68:301-303, Tippmann-Peikert,M.,et al, 2007

Cardiac Valve Regurgitation With Pergolide Compared With Nonergot Agonsits in Parkinson Disease
Arch Neurol 64:377-380, Dewey,R.B.,Jr, et al, 2007

Zolmitriptan Nasal Spray in the Acute Treatment of Cluster Headache: A Double-Blind Study
Neurol 69:821-826, Rapoport,A.M.,et al, 2007

Daclizumab Phase II Trial in Relapsing and Remitting Multiple Sclerosis
Neurol 69:785-789, Rose,J.W.,et al, 2007

Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007

Sumatriptan-Naproxen for Acute Treatment of Migraine, A Randomized Trial
JAMA 297:1443-1454, Brandes,J.L.,et al, 2007

Advanced Parkinson Disease Treated with Rotigotine Transdermal System PREFER Study
Neurol 68:1262-1267, LeWitt,P.A.,et al, 2007

Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007

Transdermal Rotigotine: Double-Blind, Placebo-Controlled Trial in Parkinson Disease
Arch Neurol 64:676-682, Jankovic,J.,et al, 2007

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007

Refractory Neurosarcoidosis Responsive to Infliximab
Pract Neurol 7:112-115, Kobylecki,C. &Shaunak,S., 2007

Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007

Risk Factors for the Development of Pedal Edema in Patients Using Pramipexole
Arch Neurol 64:820-824, Kleiner-Fisman,G. &Fisman,D.N., 2007

Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis
The Neurologist 13:182-187, Johnson,K.P., 2007

Progressive Multifocal Leukoencephalopathy After Rituximab in a Case of Non-Hodgkin Lymphoma
Neurol 69:704-706, Kranick,S.M.,et al, 2007

Treatment Options in the Modern Management of Parkinson Disease
Arch Neurol 64:1083-1088, Schapira,A.H.V., 2007

Limbic Encephalitis and Variants: Classification, Diagnosis and Treatment
Neurologist 13:261-271, Tuzun,E. &Dalmau,J., 2007

Showing articles 300 to 350 of 687 << Previous Next >>